Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Guardian community team

People affected by Alzheimer’s: share your views on the new Alzheimer’s drug

Lilly, the maker of donanemab, the new Alzheimer’s treatment.
Lilly, the maker of donanemab, the new Alzheimer’s treatment. Photograph: Darron Cummings/AP

A new Alzheimer’s drug has slowed cognitive decline by 35% raising the prospect of a second effective treatment for the disease.

It could, said Dr Richard Oakley, the associate director of research at the Alzheimer’s Society in the UK, be the “beginning of the end of Alzheimer’s disease”.

We’re looking to talk to people affected by Alzheimer’s about this news.

Do you have Alzheimer’s, or care for someone with the disease, and are hopeful about what this could mean for you and your loved ones? Or have you lost someone to Alzheimer’s, and the news is bittersweet?

Callout

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.